Tally Levy

Tel Aviv University — Israel

Medicine · Health Sciences

34h-index4.8kcitations179works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(76), Endometrial and Cervical Cancer Treatments(72), Uterine Myomas and Treatments(26), Cervical Cancer and HPV Research(20), Reproductive Biology and Fertility(17)

Publications178 total

Laparoscopic Management of Intra-Abdominal Bleeding Following Vaginal Hysterectomy, Bilateral Salpingo-Oophorectomy and Pelvic Organ Prolapse Surgery
International Urogynecology Journal·2025
First-line lenvatinib plus pembrolizumab versus chemotherapy for advanced endometrial cancer: 1-Year follow-up after final analysis of the ENGOT-en9/LEAP-001 phase 3 trial
International Journal of Gynecological Cancer·2025· 1 cited
Increasing incidence of endometrial cancer demands global action
The Lancet Obstetrics Gynaecology & Women s Health·2025
Revisiting the paradigm: Asymptomatic high-grade endometrial cancer diagnosis is not associated with improved outcomes
European Journal of Surgical Oncology·2025
The Incidence Of Breast Cancer In Ovarian Cancer Patients With BRCA Mutations: A Multicentre Retrospective Cohort Study.
International Journal of Gynecological Cancer·2025
Pre-operative platelet-to-lymphocyte ratio can help predict residual disease after primary debulking surgery for epithelial ovarian cancer
International Journal of Gynecological Cancer·2024
Examining health-related quality of life outcomes among older patients with advanced ovarian cancer treated with niraparib first-line maintenance therapy in context with efficacy and safety findings: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Gynecologic Oncology·2024
EV460/#1076  Use of a video conversation artificial intelligence application for assessing patient-reported outcomes among endometrial and ovarian cancer patients receiving chemotherapy
2024
EV120/#810  Assessing the role of PET CT in lymph node metastasis prediction for endometrial cancer staging
2024
LB012/#1602  ENGOT-en11/GOG-3053/KEYNOTE-B21: phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer
2024
SF008/#1203  Laparoscopic abdominal cerclage following trachlectomy for fertility preservation
2024
ENGOT-en11/GOG-3053/KEYNOTE-B21: a randomised, double-blind, phase III study of pembrolizumab or placebo plus adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed, high-risk endometrial cancer
Annals of Oncology·2024· 64 cited
737P Characterization of tumor response with lenvatinib plus pembrolizumab (LEN + Pembro) in the ENGOT-en9/LEAP-001 study
Annals of Oncology·2024· 1 citedOpen Access
Tolerability of the niraparib individualized starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy
European Journal of Cancer·2024· 6 citedOpen Access
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Gynecologic Oncology·2024· 6 citedOpen Access
44O Safety and efficacy results in patients who received dose modifications in the phase III MIRASOL (GOG 3045/ENGOT-ov55) trial of mirvetuximab soravtansine vs investigator’s choice chemotherapy (ICC) in platinum-resistant ovarian cancer (PROC) with high folate receptor-alpha expression
ESMO Open·2024Open Access
#556 Tolerability of the niraparib individualised starting dose in the PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib first-line maintenance therapy
2024
187 Selinexor maintenance for patients with TP53wt advanced or recurrent endometrial cancer: long-term follow up of efficacy and safety subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
2024· 2 cited
The Poor Prognosis of Acquired Secondary Platinum Resistance in Ovarian Cancer Patients
Cancers·2024· 14 citedOpen Access
<scp>D&amp;C</scp> has the best concordance between preoperative and postoperative grades among morbidly obese endometrial cancer patients
Journal of obstetrics and gynaecology research·2023· 3 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Zion Ben‐Rafael(11), Ofer Lavie(8), Joseph Menczer(7), Ofer Gemer(7), Dov Dicker(6), Alon Ben Arie(6), Mansoor Raza Mirza(5), Roy Homburg(5), Dov Feldberg(5), Ilan Bruchim(5), Michael Gdalevich(5), David Cibula(4), Jacob Ashkenazi(4), Tamar Safra(4), Arie Dekel(4), Ram Eitan(4), Hanoch Levavi(4), Antonio González-Martı́n(3), Jonathan A. Ledermann(3), Christian Marth(3)